Section 6
Chapter 5,189

Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization

Saemundsen, A.K.; Purtilo, D.T.; Sakamoto, K.; Sullivan, J.L.; Synnerholm, A.C.; Hanto, D.; Simmons, R.; Anvret, M.; Collins, R.; Klein, G.

Cancer Research 41(11 Pt 1): 4237-4242


ISSN/ISBN: 0008-5472
PMID: 6272968
Accession: 005188566

Tissues from patients thought to have Epstein-Barr virus (EBV)-induced lymphoproliferative diseases were probed for EBV genomes using 2 independent hybridization techniques. Tissues from 6 patients with the X-linked lymphoproliferative syndrome, all 5 renal allograft recipients with immunoblastic sarcoma and 8 patients with diverse types of immunodeficiency and lymphoproliferative diseases such as fatal infectious mononucleosis or malignant lymphoma associated with antecedent immunodeficiency contained significant numbers of EBV genome equivalents per cell. The use of 2 hybridization probes is recommended to confirm the presence of EBV genomes. The finding of significant numbers of EBV genomes in tissues from patients with immunodeficiency suggests that EBV is the etiological agent of the associated lymphoproliferative diseases.

PDF emailed within 1 workday: $29.90